| FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
C9orf88 |
IPI00456750 |
6.145 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
CDC42BPA |
CDC42BPA: Serine/threonine-protein kinase MRCK alpha |
6.145 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
MARK2 |
IPI00555838 |
6.145 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
TJP2 |
TJP2, X104, ZO2: Tight junction protein ZO-2 |
6.145 |
Evidence |
|
| CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
CDC42EP1 |
CDC42EP1, BORG5, CEP1, MSE55: Cdc42 effector protein 1 |
6.145 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
GRB10 |
IPI00012752 |
6.145 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PTPN11 |
PTPN11, PTP2C, SHPTP2: Tyrosine-protein phosphatase non-receptor type 11 |
6.145 |
Evidence |
|
| CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
MAP3K9 |
MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 |
6.145 |
Evidence |
|
| GJA1 |
GJA1, GJAL: Gap junction alpha-1 protein |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
6.145 |
Evidence |
|
| IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
STAT3 |
|
6.145 |
Evidence |
|
| CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| ITGB4 |
IPI00027422 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
GRB10 |
IPI00012752 |
6.145 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
6.145 |
Evidence |
|
| GJB1 |
GJB1, CX32: Gap junction beta-1 protein |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
6.145 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PPP1R1B |
PPP1R1B, DARPP32: Protein phosphatase 1 regulatory subunit 1B |
6.145 |
Evidence |
|